Already approved for progressive multiple sclerosis, ocrelizumab in a second phase 3 study demonstrates meaningful clinical ...

In a further comparison using DPP-4i/SU as the reference, the GLP-1 RA/SGLT2i combination therapy had the greatest effect in ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

The shares of GlaxoSmithKline ($GSK) cheered on Monday after the British pharmaceutical giant announced that its chief ...

Cerebras Systems' dinner plate-size chip technology has been a curiosity since the company introduced the Wafer Scale Engine ...

The market is primed for growth, driven by innovations in stem cell therapies, gene editing, and tissue engineering ...

Leucovorin, also known as folinic acid, is a form of folate, an essential B vitamin, or B9. Leucovorin has been approved by ...

Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

Autism Research EXPERT Says Trump’s TYLENOL Claims ‘EXTREME’ & ‘DEVASTATING’ | SUNRISE The Trump administration is touting an old generic drug as a ...

When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn’t the only threat facing her son. Born ...

Walmsley, who became CEO of the U.K. drugmaker in 2017 and is due to step down at the end of the year, led GSK through the Covid-19 pandemic, a fight with activist investor Elliott Management, and a ...

Trump announced another round of wide-ranging tariffs, sparking questions about their implications for consumers and businesses.